Prevalence of anti-HCV in Norwegian blood donors with anti-HBc or increased ALT levels
- 1 November 1990
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 30 (9) , 776-779
- https://doi.org/10.1046/j.1537-2995.1990.30991048780.x
Abstract
Testing for hepatitis B core antibodies (anti‐HBc) was performed in 12,104 consecutive blood donors, 139 (1.15%) of whom were found to be positive. The first 6036 donors were also screened for ALT; 91 (1.51%) had repeatedly elevated values. ALT screening was of no help in detecting anti‐HBc‐positive donors. Those with anti‐HBc or repeatedly raised ALT levels were further tested for hepatitis C virus antibodies (anti‐HCV), and 3 (2.16%) and 1 (1.10%) anti‐HCV‐positive donors were detected, respectively. This prevalence of anti‐HCV (0.5%) is not significantly different from that found in 1000 unselected donors at our blood bank. Testing for ALT and anti‐HBc as surrogate markers for hepatitis C is therefore not recommended in Norwegian blood donors and should be replaced by anti‐HCV screening.This publication has 7 references indexed in Scilit:
- Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen‐negative hepatitis B virus carrierTransfusion, 1990
- HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAINThe Lancet, 1989
- An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B HepatitisScience, 1989
- Persistent Alanine Aminotransferase Elevation in Healthy Swedish Blood Donors ‐ Mainly Caused by ObesityVox Sanguinis, 1988
- Serum ALT levels. Effect of sex, race, and obesity on unit rejection rateTransfusion, 1988
- Hepatitis B Virus Antibody in Blood Donors and the Occurrence of Non-A, Non-B Hepatitis in Transfusion RecipientsAnnals of Internal Medicine, 1984
- Serum Alanine Aminotransferase of Donors in Relation to the Risk of Non-A,Non-B Hepatitis in RecipientsNew England Journal of Medicine, 1981